Close Menu
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    BusinessNewsAsia.comBusinessNewsAsia.com
    Subscribe
    • Home
    • Top Stories
    • Business
    • Tech
    • Companies
    • Events
    • Announcements
    BusinessNewsAsia.comBusinessNewsAsia.com
    Home»Construction»ACROMEC’s associated Life Science Incubator launches Co-working Labspace
    Construction

    ACROMEC’s associated Life Science Incubator launches Co-working Labspace

    Marie JonesBy Marie JonesSeptember 24, 2021No Comments3 Mins Read
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Serving start-ups in MedTech, Biotech, Biopharma and FoodTech, the Incubator aims to become a vibrant centre of entrepreneurship, technology and science.

    ACROMEC Limited (ACROMEC; SGX: 43F), a specialist engineering services provider, announced that subsidiary ACROMEC Engineers Pte Ltd (ACROMEC Engineers) through joint-venture associate Life Science Incubator Pte Ltd, has launched the first Life Science Incubator co-working laboratory space, with a ceremony on location at the German Centre, International Business Plaza, Singapore.

    The ceremony was attended by Mr Alvin Tan, Minister of State, Ministry of Culture, Community and Youth and Ministry of Trade & Industry and others from the Economic Development Board, Enterprise Singapore, SGInnovate, A*STAR, NTUitiv and NUS accelerator. Members of Life Science Incubator’s current network of some 20 industry partners, including Merck, also attended the event.

    Serving early-stage bio and pharma start-ups, companies and entrepreneurs in the MedTech, Biotech, Biopharma and FoodTech sectors, Life Science Incubator will provide flexible co-working laboratory spaces for research and development. With access to communal state-of-the-art technologies and facilities, start-ups will be able to fully focus on innovation and talent in science without having to think about hefty infrastructure capital.

    Said Niamh Madden, General Manager of Life Science Incubator, “Today marks the start of our exciting journey at the Life Science Incubator. We look forward to supporting science and technology start-ups and being an integral launchpad for their endeavours. With our strong network of partner companies, we are confident that the incubator will become a vibrant centre of entrepreneurship, technology and science.”

    Said Mr Lim Say Chin, Executive Chairman and Managing Director of ACROMEC, “The successful completion and launch of the Life Science Incubator attests to ACROMEC’s track record and success as a specialist engineering provider for controlled environments. We are excited to be a part of this vibrant ecosystem and will continue to serve companies and start-ups in the life science, biotech, healthcare, and research sectors.”

    In July, the Group announced that wholly-owned subsidiary ACROMEC Engineers had entered into a joint-venture agreement with strategic partner Tako Ventures to build, own, and operate JVCo and co-working laboratory facilities. JVCo is 30% owned by the Group through ACROMEC Engineers, while Tako Ventures holds the remaining 70% stake, managing JVCo and the Life Science Incubator.

    ACROMEC Engineers undertook the design, construction, and fitting-out works for the 600 square meter Life Science Incubator’s co-working lab facilities, which includes 8 suites, 51 lab benches, and 1 operating theatre.

    About ACROMEC Limited
    SGX Catalyst-listed ACROMEC (SGX: 43F) is an established specialist engineering services provider with more than 20 years of acquiring expertise in the design and construction of facilities requiring controlled environments, such as laboratories, medical and sterile facilities and cleanrooms. Amongst its customers, ACROMEC counts hospitals & medical centres, government agencies, educational institutions, research & development companies and multinational units, pharmaceutical, semiconductor manufacturing and engineering companies. For more information, visit www.acromec.com.

    ACROMEC share information through SGX (43F), Bloomberg (ACRO.SG) and ThomsonReuters (ACRO.SI).

    Analyst & Media contact:
    ACROMEC Limited
    Mr Jerry Tan, CFO
    E: jerry.tan@acromec.com

    Waterbrooks Consultants Pte Ltd
    Mr Wayne Koo / Ms Raihana
    T: +65 6958 8002 / +65 9338 8166
    E: wayne.koo@waterbrooks.com.sg / raihana@waterbrooks.com.sg

    ACROMEC Engineers / Life Sciences Incubator
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleChinese language learning startup T-Lab raises US$ 1.6 million in seed funding round led by East Ventures
    Next Article Agilex Biolabs Announced as Citeline Award Finalist for COVID-19 Vaccine Toxicology Preclinical Research

    Related Posts

    Everest Medicines and Hainan Herui have entered into a commercialization collaboration relating to Hainan Herui’s budesonide enteric capsules, further enhancing patient access to the medication

    June 24, 2026

    JBM Healthcare Announces FY2026 Annual Results

    June 22, 2026

    CMS: Class 1 Innovative Drug Silevimig Injection Approved in China, Becoming the World’s First Bispecific Antibody for Passive Immunization Against Rabies

    June 22, 2026
    Add A Comment

    Comments are closed.

    © 2026 BusinessNewsAsia.com
    • About Us
    • Contact Us
    • BusinessNews.ph
    • AsiaPEVC.com
    • DevFiNews.com
    • RenewableEnergy.ph

    Type above and press Enter to search. Press Esc to cancel.